Hypoglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies
Richard Silbert1, Alejandro Salcido-Montenegro2,3, Rene Rodriguez-Gutierrez2,3,4
1Department of Medicine Residency Program, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Hypoglycemia, a common complication of type 2 diabetes therapy, poses significant risks. Patient-centered, multidisciplinary care strategies are emerging to identify and manage hypoglycemia risk factors effectively.
Area of Science:
- Endocrinology and Metabolism
- Diabetes Mellitus Research
- Public Health and Epidemiology
Background:
- Hypoglycemia is a frequent and serious adverse effect of diabetes treatment, often limiting therapeutic options.
- Despite being preventable, hypoglycemia in type 2 diabetes (T2DM) leads to considerable personal and societal costs.
Purpose of the Study:
- To review the epidemiology of hypoglycemia in patients with type 2 diabetes.
- To discuss the primary risk factors associated with hypoglycemia.
- To introduce potential strategies for the prevention of hypoglycemia.
Main Methods:
- Review of existing literature on hypoglycemia rates, definitions, and measurement in type 2 diabetes.
- Analysis of data from randomized controlled trials and observational studies.
- Examination of patient-reported outcomes and risk factor prevalence.
Main Results:
- Hypoglycemia rates in T2DM vary widely due to heterogeneous reporting; severe hypoglycemia rates range from 0.7 to 12 per 100 person-years in RCTs.
- Patient-reported symptomatic hypoglycemia is more common, affecting up to 58% of non-insulin users and 64% of insulin users over specified periods.
- Key risk factors include older age, comorbidities, long diabetes duration, prior hypoglycemia, insulin/sulfonylurea use, food insecurity, and fasting.
Conclusions:
- Hypoglycemia is a prevalent issue in type 2 diabetes management.
- Multidisciplinary, patient-centered care, including treatment de-intensification and diabetes technology, shows promise in reducing hypoglycemia.
- Further prospective trials are needed to validate hypoglycemia risk reduction strategies.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Hypoglycemia and Glucagon
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Titrimetric Methods: Types and Commonly Used Strategies


